På denne side bringer DANSK BIOTEK nyheder fra medlemmerne, som på denne måde får mulighed for at blive ekstra eksponeret.

Vi modtager derfor gerne pressemeddelelser og andre nyheder. Send dem til Dorte Dannemann, hjælp af denne formular.

10 Apr 2013

IMPROVING CELL BASED ASSAYS THROUGH VIRAL VECTOR TECHNOLOGY

Requirements for cell based assays have induced a rapid development of novel cell models. To improve the effectiveness of target research and compound development the use of patient or stem cell-derived cell models is becoming increasingly important. SIRION Biotech specializes in viral vector technology and provides sophisticated cell modeling.

Experience how viral vector technology can enable you to generate primary cell-based models with homogenous gene expression for high content screening or phenotypic analysis. Combined with a unique RNAi technology and expertise in cell culture SIRION Biotech offers access to in depth functional gene analysis.

Registration (free of charge):

http://www.mva.org/improving-cell-based-assays-through-viral-vector-technology-0

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or 28895854

Copyright 2013 Danskbiotek. All rights reserved.